Search Filters
Advanced Search
SMC ID Date Medicine Submission Type Indication
1224/17 10/04/2017 ticagrelor (Brilique) Full Co-administered with acetylsalicylic acid for the prevention of atherothrombotic events in adult patients with a history of myocardial infarction and a high risk of developing an atherothrombotic event.
699/11 09/05/2011 ticagrelor (Brilique) Full Co-administered with aspirin, for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (unstable angina, non ST elevation myocardial infarction [NSTEMI] or ST elevation myocardial infarction [STEMI]); including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery by-pass grafting (CABG).

No medicines have been found.